GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ALR Technologies SG Ltd (OTCPK:ALRTF) » Definitions » Beta

ALR Technologies SG (ALR Technologies SG) Beta : 1.44 (As of May. 04, 2024)


View and export this data going back to 1998. Start your Free Trial

What is ALR Technologies SG Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-04), ALR Technologies SG's Beta is 1.44.


ALR Technologies SG Beta Historical Data

The historical data trend for ALR Technologies SG's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ALR Technologies SG Beta Chart

ALR Technologies SG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.61 13.85 0.03 -0.77 0.66

ALR Technologies SG Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Jun23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.77 -0.59 -0.25 0.66 1.53

Competitive Comparison of ALR Technologies SG's Beta

For the Medical Devices subindustry, ALR Technologies SG's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ALR Technologies SG's Beta Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ALR Technologies SG's Beta distribution charts can be found below:

* The bar in red indicates where ALR Technologies SG's Beta falls into.



ALR Technologies SG Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


ALR Technologies SG  (OTCPK:ALRTF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


ALR Technologies SG Beta Related Terms

Thank you for viewing the detailed overview of ALR Technologies SG's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


ALR Technologies SG (ALR Technologies SG) Business Description

Traded in Other Exchanges
N/A
Address
7400 Beaufont Springs Drive, Suite 300, Richmond, VA, USA, 23225
ALR Technologies SG Ltd formerly ALR Technologies Inc is a medical device company, which focuses on commercializing its Health-e-Connect System. It has developed a compliance monitoring system that will allow healthcare professionals to remotely monitor patient health conditions and provide patient health management. The company's Health-e-Connect Remote Diabetes Management Program is remote monitoring and care facilitation program that allows patients to upload their blood glucose data from their glucometers. Its geographical segments are the United States, Singapore, and Others.
Executives
Sidney Chan director, officer: CEO 7400 BEAUFONT SPRINGS DRIVE, SUITE 300, SUITE 300, RICHMOND VA 23225
Ronald Cheng director 255 SPRINGFIELD ROAD, OTTAWA A6 K1M 0K8
Peter H Stafford director 1-405 81ST STREET, OSOYOOS A1 V0H 1V2
William S Smith director, officer: Chief Commercial Officer 46 CHESTNUT HILL ROAD, WILTON CT 06897
Kenneth Robulak director 521 MANDALAY AVENUE, APT. 302, CLEARWATER FL 33767
Alfonso Salas director 2106 WEST 33RD AVENUE, VANCOUVER A1 V6M 1B9
Lawrence A Weinstein director, officer: President 13436 BLUE HEON LOOP, CHESTERFIELD VA 23838
Jaroslav V Tichy officer: Vice-President - Technologies 114M REYNOLDA VILLAGE, WINSTON-SALEM NC 27106
Stanley Cruitt director, 10 percent owner, officer: President 114M REYNOLDA VILLAGE, WINSTON-SALEM NC 27106